Differential Effects of IL-1α and IL-1β on Tumorigenicity Patterns and Invasiveness

Journal of Immunology

Volumn 171, Issue 12, 2003, Pages 6448-6456

  Song, Xiaoping ^a   Voronov, Elena ^a   Dvorkin, Tatyana ^a   Fima, Eyal ^a   Cagnano, Emanuela ^a   Benharroch, Daniel ^a   Shendler, Yaakov ^a   Bjorkdahl, Olle ^b,d   Segal, Shraga ^a   Dinarello, Charles A ^c   Apte, Ron N ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b LUND UNIVERSITY   (Sweden)

^c UNIVERSITY OF COLORADO   (United States)

^d Pharmexa AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAMYCIN A; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2;

ANGIOGENESIS; ANIMAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIOSYNTHESIS; CANCER CELL CULTURE; CANCER INVASION; CANCER TRANSPLANTATION; CARCINOGENICITY; CELL COMPARTMENTALIZATION; CELL INFILTRATION; CELL LINE; CELL MEMBRANE; CELL MOTION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL TRANSFORMATION; CLONAL ANERGY; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLOGY; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EFFECTOR CELL; FEMALE; FIBROSARCOMA; GENETIC TRANSFECTION; GENETICS; HISTOPATHOLOGY; HOST; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; IN VIVO STUDY; INTRAVENOUS DRUG ADMINISTRATION; LUNG METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MITOGENESIS; MOLECULE; MONONUCLEAR CELL; MOUSE; NATURAL KILLER CELL; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOLOGY; PHYSIOLOGY; PRECURSOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN; TUMOR CELL; TUMOR CELL LINE; TUMOR GROWTH; TUMOR IMMUNITY; TUMOR LOCALIZATION; TUMOR VASCULARIZATION; VASCULARIZATION; WILD TYPE;

EID: 10744229833     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.12.6448     Document Type: Article

References (34)

1. Apte, R. N., and E. Voronov. 2002. Interleukin-1 a major pleiotropic cytokine in tumor-host interactions. Semin. Cancer Biol. 12:277.
2. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095.
3. Douvdevani, A., M. Huleihel, M. Zoller, S. Segal, and R. N. Apte. 1992. Reduced tumorigenicity of fibrosarcomas which constitutively generate IL-1α either spontaneously or following IL-1α gene transfer. Int. J. Cancer 51:822.
4. Zoller, M., A. Douvdevani, S. Segal, and R. N. Apte. 1992. Interleukin-I produced by tumorigenic fibroblasts influences tumor rejection. Int. J. Cancer 50:443.
5. Zoller, M., A. Douvdevani. S. Segal, and R. N. Apte. 1992. Interleukin-1 production by transformed fibroblasts. II. Influence on antigen presentation and T-cell-mediated anti-tumor response. Int. J. Cancer 50:450.
6. Apte, R. N., A. Douvdevani, M. Zoller, R. M. White, T. Dvorkin, N. Shimoni, E. Fima, M. Hacham, M. Huleihel, D. Benharroch, E. Voronov, and S. Segal. 1993. Cytokine-induced tumor immunogenicity: endogenous interleukin-1α expressed by fibrosarcoma cells confers reduced tumorigenicity. Immunol. Lett. 39:45.
7. Voronov, E., Y. Weinstein, D. Benharroch, E. Cagnano, R. Ofir, M. Dobkin, R. M. White, M. Zoller, V. Barak, S. Segal, and R. N. Apte. 1999. Antitumor and immunotherapeutic effects of activated invasive T lymphoma cells that display short-term interleukin 1α expression. Cancer Res. 59:1029.
8. Wingren, A. G., O. Björkdahl, T. Labuda, L. Björk, U. Andersson, U. Gullberg, G. Hedlund, H. O. Sjögren, T. Kalland, B. Widegren, and M. Dohlsten. 1996. Fusion of a signal sequence to the interleukin-1β gene directs the protein from cytoplasmic accumulation to extracellular release. Cell. Immunol. 169:226.
9. Fredrickson, T. N., J. W. Hartley, N. K. Wolford, J. H. Resau, U. R. Rapp, H. C. Morse III. 1988. Histogenesis and clonality of pancreatic tumors induced by v-myc and v-raf oncogenes in NFS/N mice. Am. J. Pathol. 131:444.
10. Weidner, N., J. P. Semple, W. R. Welch, and J. Folkman. 1991. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med. 324:1.
11. Tsukuda, M., I. Mochimatsu, M. Sakumoto, Y. Mikami, S. Yuyama, and S. Yanoma. 1993. The synergistic effects of interleukin 2 and interleukin 7 on the proliferation and autologous tumor cell lysis of tumor-associated lymphocytes. Biotherapy 6:167.
12. Kalli, K., C. Huntoon, M. Bell, and D. J. McKean. 1998. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-κB. Mol. Cell. Biol. 18:3140.
13. Marr, R. A., C. L. Addison, D. Snider, W. J. Muller, J. Gauldie, and F. L. Graham. 1997. Tumour immunotherapy using an adenoviral vector expressing a membrane-bound mutant of murine TNFα. Gene Ther. 4:1181.
14. el-Shami, K. M., E. Tzehoval, E. Vadai, M. Feldman, and L. Eisenbach. 1999. Induction of antitumor immunity with modified autologous cells expressing membrane-bound murine cytokines. J. Interferon Cytokine Res. 19:1391.
15. Soo Hoo, W., K. A. Lundeen, J. R. Kohrumel, N. L. Pham, S. W. Brostoff, R. M. Bartholomew, and D. J. Carlo. 1999. Tumor cell surface expression of granulocyte-macrophage colony-stimulating factor elicits antitumor immunity and protects from tumor challenge in the P815 mouse mastocytoma tumor model. J. Immunol. 162:7343.
16. Ferrari, D., S. Wesselborg, M. K. Bauer, and K. Schulze-Osthoff. 1997. Extra-cellular ATP activates transcription factor NF-κB through the P2Z purinoreceptor by selectively targeting NF-κB p65. J. Cell Biol. 139:1635.
17. Saijo, Y., M. Tanaka, M. Miki, K. Usui, T. Suzuki, M. Maemondo, X. Hong, R. Tazawa, T. Kikuchi, K. Matsushima, and T. Nukiwa. 2002. Proinflammatory cytokine IL-1β promotes tumor growth of Lewis lung carcinoma by induction of angiogenic factors: in vivo analysis of tumor-stromal interaction. J. Immunol. 169:469.
18. Voronov. E., D. S. Shouval, Y. Krelin, E. Cagnano, D. Benharroch, Y. Iwakura, C. A. Dinarello, and R. N. Apte. 2003. IL-1 is required for tumor invasiveness and angiogenesis. Proc. Natl. Acad. Sci. USA 100:2645.
19. Chirivi, R. G., A. Garofalo, I. M. Padura, A. Mantovani, and R. Giavazzi. 1993. Interleukin 1 receptor antagonist inhibits the augmentation of metastasis induced by interleukin 1 or lipopolysaccharide in a human melanoma/nude mouse system. Cancer Res. 53:5051.
20. Chirivi, R. G., C. Chiodoni, P. Musiani, A. Garofalo, S. Bernasconi, M. P. Colombo, and R. Giavazzi. 1996. IL-1α gene-transfected human melanoma cells increase tumor-cell adhesion to endothelial cells and their retention in the lung of nude mice. Int. J. Cancer 67:856.
21. McKenzie, R. C., A. Oran, C. A. Dinarello, and D. N. Sauder. 1996. Interleukin-1 receptor antagonist inhibits subcutaneous B16 melanoma growth in vivo. Anticancer Res. 16:437.
22. Scherbarth, S., and F. W. Orr. 1997. Intravital videomicroscopic evidence for regulation of metastasis by the hepatic microvasculature: effects of interleukin-1α on metastasis and the location of B16F1 melanoma cell arrest. Cancer Res. 57:4105.
23. Anasagasti, M. J., E. Olaso, F. Calvo, L. Mendoza, J. J. Martin, J. Bidaurrazaga, and F. Vidal-Vanaclocha. 1997. Interleukin 1-dependent and -independent mouse melanoma metastases. J. Natl. Cancer Inst. 89:645.
24. Bennicelli, J. L., J. Elias, J. Kern, and D. Guerry IV. 1989. Production of interleukin 1 activity by cultured human melanoma cells. Cancer Res. 49:930.
25. Vidal-Vanaclocha, F., C. Amezaga, A. Asumendi, G. Kaplanski, and C. A. Dinarello. 1994. Interleukin-1 receptor blockade reduces the number and size of murine B16 melanoma hepatic metastases. Cancer Res. 54:2667.
26. Vidal-Vanaclocha, F., A. Alvarez, A. Asumendi, B. Urcelay, P. Tonino, and C. A. Dinarello. 1996. Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo: increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J. Natl. Cancer Inst. 88:198.
27. + suppressor T cells. Immunol. Rev. 182:58.
28. Mantovani, A., B. Bottazzi, F. Colotta, S. Sozzani, and L. Ruco. 1992. The origin and function of tumor-associated macrophages. Immunol. Today 13:265.
29. Whiteside, T. L. 1999. Signaling defects in T lymphocytes of patients with malignancy. Cancer Immunol. Immunother. 48:346.
30. Joseph, S. B., K. T. Miner, and M. Croft. 1998. Augmentation of naive, Th1 and Th2 effector CD4 responses by IL-6, IL-1 and TNF. Eur. J. Immunol. 28:277.
31. Hunter, C. A., J. Timans, P. Pisacane, S. Menon, G. Cai, W. Walker, M. Aste-Amezaga, R. Chizzonite, J. F. Bazan, and R. A. Kastelein. 1997. Comparison of the effects of interleukin-1α, interleukin-1β and intefferon-γ-inducing factor on the production of interferon-γ by natural killer. Eur. J. Immunol. 27:2787.
32. Alves-Rosa, F., M. Vulcano, M. Beigier-Bompadre, G. Fernandez, M. Palermo, and M. A. Isturiz. 2002. Interleukin-1β induces in vivo tolerance to lipopolysaccharide in mice. Clin. Exp. Immunol. 128:221.
33. Björkdahl, O., A. G. Wingren, G. Hedhund, L. Ohlsson, and M. Dohlsten. 1997. Gene transfer of a hybrid interleukin-1β gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo. Cancer Immunol. Immunother. 44:273.
34. Björkdahl, O., M. Dohlsten, and H. O. Sjögren. 2000. Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1β induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Cancer Gene Ther. 7:1365.